Northern Trust’s Spero Therapeutics SPRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$292K Sell
100,831
-93
-0.1% -$270 ﹤0.01% 3812
2025
Q1
$72.7K Buy
100,924
+14,477
+17% +$10.4K ﹤0.01% 4168
2024
Q4
$89K Sell
86,447
-25,050
-22% -$25.8K ﹤0.01% 4176
2024
Q3
$149K Sell
111,497
-806
-0.7% -$1.08K ﹤0.01% 3963
2024
Q2
$146K Sell
112,303
-2,256
-2% -$2.93K ﹤0.01% 3954
2024
Q1
$197K Buy
114,559
+25,678
+29% +$44.2K ﹤0.01% 3900
2023
Q4
$131K Hold
88,881
﹤0.01% 4044
2023
Q3
$108K Buy
88,881
+136
+0.2% +$165 ﹤0.01% 3994
2023
Q2
$129K Buy
88,745
+2,489
+3% +$3.61K ﹤0.01% 3968
2023
Q1
$125K Buy
86,256
+16,672
+24% +$24.2K ﹤0.01% 4025
2022
Q4
$120K Sell
69,584
-379
-0.5% -$656 ﹤0.01% 4033
2022
Q3
$140K Sell
69,963
-5
-0% -$10 ﹤0.01% 4011
2022
Q2
$52K Sell
69,968
-168,484
-71% -$125K ﹤0.01% 4403
2022
Q1
$2.07M Sell
238,452
-14,748
-6% -$128K ﹤0.01% 3080
2021
Q4
$4.05M Sell
253,200
-4,739
-2% -$75.9K ﹤0.01% 2818
2021
Q3
$4.75M Sell
257,939
-2,947
-1% -$54.2K ﹤0.01% 2767
2021
Q2
$3.64M Buy
260,886
+21,308
+9% +$297K ﹤0.01% 3029
2021
Q1
$3.53M Sell
239,578
-26,395
-10% -$389K ﹤0.01% 2957
2020
Q4
$5.16M Buy
265,973
+54,896
+26% +$1.06M ﹤0.01% 2664
2020
Q3
$2.36M Buy
211,077
+1,160
+0.6% +$12.9K ﹤0.01% 2984
2020
Q2
$2.84M Buy
209,917
+46,643
+29% +$631K ﹤0.01% 2838
2020
Q1
$1.32M Buy
163,274
+27,277
+20% +$221K ﹤0.01% 3073
2019
Q4
$1.31M Buy
135,997
+15,913
+13% +$153K ﹤0.01% 3306
2019
Q3
$1.27M Buy
120,084
+26,334
+28% +$279K ﹤0.01% 3311
2019
Q2
$1.08M Buy
93,750
+5,416
+6% +$62.3K ﹤0.01% 3334
2019
Q1
$1.13M Sell
88,334
-8,499
-9% -$109K ﹤0.01% 3315
2018
Q4
$595K Buy
96,833
+1,038
+1% +$6.38K ﹤0.01% 3515
2018
Q3
$1.01M Buy
95,795
+29,145
+44% +$306K ﹤0.01% 3468
2018
Q2
$978K Buy
66,650
+291
+0.4% +$4.27K ﹤0.01% 3458
2018
Q1
$945K Buy
66,359
+1,234
+2% +$17.6K ﹤0.01% 3392
2017
Q4
$765K Buy
+65,125
New +$765K ﹤0.01% 3472